Top Markets
Coin of the day
Solasia Pharma K.K. Solasia Pharma K.K.

Solasia Pharma K.K.

4597
Clasificación en acciones #24757
Established in 2006 and headquartered in Tokyo, Japan, Solasia Pharma K.K. is... Established in 2006 and headquartered in Tokyo, Japan, Solasia Pharma K.K. is dedicated to the development and commercialization of oncology treatments throughout Japan and other parts of Asia. The company's marketed products include SP-03 (episil oral liquid), designed for the protection and relief of oral pain and inflammation (mucositis/stomatitis) resulting from cancer chemotherapy and radiation. Additionally, they offer SP-01 (Sancuso), a transdermal patch that delivers granisetron, an anti-emetic, into the bloodstream to manage chemotherapy-induced nausea and vomiting. Solasia Pharma's development pipeline features SP-02 (Darinaparsin), a mitochondrial-targeted agent that has successfully completed Phase III clinical trials for a range of hematologic and solid cancers. Also in Phase III clinical study is SP-05 (Arfolitixorin), which aims to bolster the anti-tumor effectiveness of fluorouracil in various cancers, including pancreatic, breast, stomach, and head and neck cancers. In its pre-clinical stage, SP-04 is being developed to address chemotherapy-induced peripheral neuropathy.
Precio por acción
$0.20877985
Capitalización bursátil
$57.00M
Cambio (1 día)
-11.11%
Cambio (1 año)
-20.59%
País
JP
Comercio Solasia Pharma K.K. (4597)

Categoría

Precio 4597 con Capital del mercado a B
Solasia Pharma K.K. Solasia Pharma K.K.
4597
$0.20877985
Capitalización de mercado de Solasia Pharma K.K.(4597)
Capitalización bursátil: $57.00M
A fecha de August 2026, Solasia Pharma K.K. tiene una capitalización de mercado de $57.00M. Esto convierte a Solasia Pharma K.K. en la 24757th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Solasia Pharma K.K. desde 2017 hasta 2026
4597 en comparación con los más populares 5 títulos stocks
Precio por 4597 Activo B Capital del mercado en B Resultados
Solasia Pharma K.K. Solasia Pharma K.K.
$19,255.33 $57.00M
$5.257T +9,222,689.99%
Solasia Pharma K.K. Solasia Pharma K.K.
$16,844.41 $57.00M
$4.599T +8,067,923.66%
Solasia Pharma K.K. Solasia Pharma K.K.
$15,034.01 $57.00M
$4.104T +7,200,789.63%
Solasia Pharma K.K. Solasia Pharma K.K.
$13,103.13 $57.00M
$3.577T +6,275,948.87%
Solasia Pharma K.K. Solasia Pharma K.K.
$10,282.88 $57.00M
$2.807T +4,925,127.16%